# § 201.24   Labeling for systemic antibacterial drug products.

The labeling of all systemic drug products intended for human use indicated to treat a bacterial infection, except a mycobacterial infection, must bear the following statements:


(a) At the beginning of the label, under the product name, the labeling must state:


(b) In the “Indications and Usage” section, the labeling must state:


(c) In the “Precautions” section, under the “General” subsection, the labeling must state:


(d) In the “Precautions” section, under the “Information for Patients” subsection, the labeling must state:



---

[N] [68 FR 6081, Feb. 6, 2003]




